Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Current Value
$17.001 Year Return
Current Value
$17.001 Year Return
Market Cap
$519.98M
P/E Ratio
-3.08
1Y Stock Return
-37.82%
1Y Revenue Growth
-3.02%
Dividend Yield
0.00%
Price to Book
0.5
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KN | 52.23% | $1.60B | +12.19% | 0.00% |
TECH | 49.36% | $10.55B | +4.49% | 0.48% |
NEO | 48.77% | $1.97B | -19.92% | 0.00% |
BEAM | 48.23% | $2.09B | -9.52% | 0.00% |
NVST | 47.86% | $3.49B | -15.41% | 0.00% |
ASTH | 47.33% | $2.01B | +24.82% | 0.00% |
GMRE | 46.83% | $579.18M | -10.99% | 9.69% |
ABCL | 46.73% | $800.44M | -37.56% | 0.00% |
ADPT | 46.63% | $661.15M | +6.16% | 0.00% |
CPS | 45.89% | $244.48M | -24.67% | 0.00% |
NTLA | 45.87% | $1.44B | -50.35% | 0.00% |
PINC | 45.66% | $2.14B | +5.54% | 3.79% |
CLFD | 45.51% | $398.66M | +4.48% | 0.00% |
DNLI | 44.79% | $3.50B | +33.66% | 0.00% |
CERS | 44.75% | $312.00M | -0.59% | 0.00% |
TDOC | 44.62% | $1.54B | -47.22% | 0.00% |
KIDS | 43.86% | $588.93M | -24.59% | 0.00% |
BLFS | 43.61% | $1.04B | +64.64% | 0.00% |
DDD | 43.32% | $402.06M | -35.13% | 0.00% |
MMSI | 43.14% | $6.10B | +45.96% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VST | -0.01% | $52.69B | +349.00% | 0.56% |
NOC | 0.13% | $71.54B | +4.23% | 1.60% |
INSG | -0.17% | $157.28M | +540.25% | 0.00% |
CEPU | -0.19% | $2.07B | +87.28% | 0.00% |
SAVA | 0.26% | $1.35B | +25.50% | 0.00% |
SYPR | 0.30% | $32.23M | -26.32% | 0.00% |
LMT | 0.30% | $126.40B | +18.99% | 2.36% |
AGX | 0.31% | $2.01B | +224.91% | 0.85% |
CYD | -0.39% | $364.46M | -2.94% | 4.26% |
VRT | -0.44% | $52.90B | +230.61% | 0.07% |
HIHO | -0.46% | $8.63M | 0.00% | 6.12% |
BAH | 0.47% | $17.62B | +9.13% | 1.47% |
PSTG | 0.51% | $16.35B | +36.41% | 0.00% |
PBT | 0.51% | $606.38M | -27.11% | 5.87% |
LITB | -0.62% | $35.48M | -75.45% | 0.00% |
ADBE | 0.66% | $219.93B | -18.23% | 0.00% |
WM | 0.75% | $87.92B | +27.58% | 1.34% |
KSPI | 0.79% | $20.86B | +18.06% | 3.37% |
TRGP | 0.82% | $44.39B | +132.49% | 1.34% |
BACK | 0.86% | $1.76M | -32.90% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | -18.17% | $27.18B | +19.50% | 1.03% |
AXON | -18.16% | $46.53B | +167.14% | 0.00% |
MCK | -14.79% | $78.15B | +35.51% | 0.42% |
LPLA | -14.18% | $23.55B | +38.13% | 0.38% |
VIST | -12.38% | $4.75B | +67.10% | 0.00% |
PULM | -9.94% | $19.83M | +202.98% | 0.00% |
TCTM | -9.22% | $8.10M | -42.99% | 0.00% |
TPST | -9.15% | $37.75M | -77.59% | 0.00% |
OXBR | -9.11% | $19.05M | +178.18% | 0.00% |
TKC | -8.95% | $5.80B | +35.51% | 1.30% |
MNOV | -8.90% | $93.19M | +2.15% | 0.00% |
BTCT | -8.46% | $42.61M | +353.33% | 0.00% |
HUSA | -7.94% | $16.69M | -11.56% | 0.00% |
RBRK | -7.41% | $8.03B | +38.16% | 0.00% |
IBKR | -7.24% | $20.20B | +131.83% | 0.37% |
FTNT | -7.13% | $69.59B | +72.67% | 0.00% |
CCEC | -7.08% | $1.02B | +28.03% | 3.26% |
PRT | -6.34% | $48.72M | -16.56% | 10.33% |
DOCS | -6.14% | $9.62B | +114.35% | 0.00% |
MNR | -5.43% | $1.66B | -10.71% | 15.90% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 58.42% | $70.59M | 0.5% |
ARKG | 55.63% | $1.13B | 0.75% |
EDOC | 54.29% | $40.86M | 0.68% |
XHE | 52.87% | $213.41M | 0.35% |
FBT | 52.59% | $1.11B | 0.56% |
IBB | 51.87% | $6.66B | 0.45% |
PBE | 51.30% | $258.53M | 0.58% |
XBI | 51.24% | $6.58B | 0.35% |
IWC | 50.16% | $933.99M | 0.6% |
IWN | 49.69% | $13.17B | 0.24% |
IWM | 49.51% | $75.73B | 0.19% |
VTWO | 49.51% | $12.38B | 0.1% |
IJS | 49.32% | $7.37B | 0.18% |
PRFZ | 49.32% | $2.65B | 0.39% |
VIOV | 49.31% | $1.44B | 0.15% |
SLYV | 48.94% | $4.16B | 0.15% |
RZV | 48.92% | $258.76M | 0.35% |
SMMV | 48.71% | $321.07M | 0.2% |
FYX | 48.57% | $959.00M | 0.6% |
RSPH | 48.27% | $885.96M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GBIL | 0.17% | $5.60B | 0.12% |
DBE | -0.37% | $50.13M | 0.77% |
DBO | 0.76% | $217.57M | 0.77% |
SGOV | -1.01% | $27.53B | 0.09% |
WEAT | -1.25% | $120.27M | 0.28% |
FLTR | -1.50% | $1.79B | 0.14% |
KRBN | 1.66% | $242.47M | 0.85% |
UNG | -1.73% | $908.80M | 1.06% |
CORN | 2.04% | $61.12M | 0.2% |
FBY | 2.10% | $127.69M | 0.99% |
DBA | -2.13% | $755.88M | 0.93% |
XHLF | 2.17% | $874.27M | 0.03% |
DXJ | 2.36% | $3.71B | 0.48% |
JUCY | 2.87% | $324.29M | 0.6% |
FMF | -3.24% | $244.61M | 0.95% |
HDRO | -3.28% | $164.26M | 0.3% |
DBJP | 3.73% | $399.93M | 0.45% |
COMT | 3.74% | $829.06M | 0.48% |
HEWJ | 3.79% | $347.32M | 0.5% |
GSG | 3.99% | $914.42M | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -34.82% | $201.97M | 0.5% |
BTAL | -33.04% | $388.04M | 1.43% |
UUP | -30.60% | $309.25M | 0.77% |
EQLS | -26.61% | $76.08M | 1% |
VIXY | -17.17% | $195.31M | 0.85% |
HIGH | -12.44% | $302.78M | 0.51% |
KCCA | -10.36% | $220.51M | 0.87% |
SOYB | -9.30% | $27.32M | 0.22% |
CTA | -9.27% | $350.27M | 0.78% |
TAIL | -8.90% | $67.98M | 0.59% |
KMLM | -8.18% | $353.87M | 0.9% |
BOXX | -8.12% | $4.43B | 0.1949% |
AGZD | -7.50% | $142.76M | 0.23% |
TBIL | -5.66% | $4.38B | 0.15% |
DBMF | -5.34% | $1.02B | 0.85% |
MINT | -4.49% | $11.62B | 0.35% |
HDRO | -3.28% | $164.26M | 0.3% |
FMF | -3.24% | $244.61M | 0.95% |
DBA | -2.13% | $755.88M | 0.93% |
UNG | -1.73% | $908.80M | 1.06% |
Yahoo
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where Fulgent Genetics, Inc. (NASDAQ:FLGT) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […]
Finnhub
EL MONTE - Fulgent Genetics, Inc. , a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its...
SeekingAlpha
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsMelanie Solomon - Investor...
Yahoo
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Yahoo
Fulgent Genetics ( NASDAQ:FLGT ) Third Quarter 2024 Results Key Financial Results Revenue: US$71.7m (down 15% from 3Q...
Yahoo
Fulgent Genetics ( (FLGT) ) has provided an announcement. Fulgent Genetics reported third-quarter 2024 financial results, showcasing a total revenue of $71.7 million with a 9% year-over-year growth in core revenue. While the company faced a GAAP loss of $14.6 million, it achieved a non-GAAP income of $9.4 million. Fulgent remains optimistic about its full-year core revenue guidance of $280 million and improved earnings per share. The company continues to advance its laboratory services and thera
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.